Ovarian Reserve Test
A woman’s chance of achieving a healthy pregnancy is influenced by many factors including her health, her lifestyle and her partner’s fertility. One of the most significant factors is her age and most women are now aware that having a baby in the late thirties or early forties is more difficult than at a younger age. Measuring a woman’s ovarian reserve may provide vital information about whether she could defer trying for a baby for a few years or whether her reproductive life span is so reduced that she should not delay.
MFS pioneered the use of inhibin B as a predictor of ovarian response to stimulation with hormones during fertility treatment and subsequently introduced the measurement of anti-Müllerian hormone (AMH) in 2006, giving an even more accurate indication of a woman’s fertility potential.
In addition to measuring a woman’s AMH, the ovarian reserve test at MFS also includes:
- measurement of the FSH hormone level and of the FSH:LH hormone ratio
- a consultation with a fertility specialist
- an ovarian ultrasound scan to perform an antral follicle count
Measuring AMH is also part of the MFS fertility investigation package and may also be included in the baseline tests or female repeat screening undertaken before treatment begins.
The MFS ovarian reserve test is available to women who have not had an initial consultation or follow-up consultation and may be offered by post, reducing the number of visits required to MFS.
Over the counter fertility testing kits may provide similar results to the MFS tests, but will not be as comprehensive and do not include an ultrasound scan, an explanation of the results by a fertility specialist or offer any counselling.
Women interested in elective egg freezing are required to undergo an ovarian reserve test at MFS a maximum of 12 months before progressing to the egg freezing preparation service and then possibly onto treatment.
Costs
Cost of ovarian reserve test at MFS: £275